ITeos Therapeutics Inc (ITOS)
13.19
+0.84
(+6.80%)
USD |
NASDAQ |
Mar 27, 16:00
13.43
+0.24
(+1.82%)
After-Hours: 20:00
ITeos Therapeutics Free Cash Flow (Quarterly): -15.16M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -15.16M |
September 30, 2023 | -34.64M |
June 30, 2023 | -30.25M |
March 31, 2023 | -26.67M |
December 31, 2022 | -27.29M |
September 30, 2022 | -29.78M |
June 30, 2022 | -30.83M |
March 31, 2022 | -24.23M |
December 31, 2021 | -58.98M |
September 30, 2021 | 604.47M |
Date | Value |
---|---|
June 30, 2021 | -18.66M |
March 31, 2021 | -14.88M |
December 31, 2020 | -5.598M |
September 30, 2020 | -10.33M |
June 30, 2020 | -10.09M |
March 31, 2020 | 0.494M |
December 31, 2019 | -6.927M |
September 30, 2019 | -5.608M |
June 30, 2019 | -5.985M |
March 31, 2019 | -5.346M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-58.98M
Minimum
Dec 2021
604.47M
Maximum
Sep 2021
12.19M
Average
-15.02M
Median
Free Cash Flow (Quarterly) Benchmarks
Gilead Sciences Inc | 1.954B |
Merck & Co Inc | -743.00M |
Arcus Biosciences Inc | -94.00M |
IGM Biosciences Inc | -49.46M |
Forian Inc | 2.806M |